News

Fifteen of the biotechnology company’s products delivered at least double-digit sales growth in the second quarter.
Amgen Inc (NASDAQ:AMGN) shares held near flat in after-hours trading Tuesday despite posting better-than-expected quarterly ...
Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...
Amgen crushed second-quarter forecasts late Tuesday. But Amgen stock fell in late-afternoon trading following its report.
The Thousand Oaks, California-based company said it had net income of $2.65 per share. Earnings, adjusted for non-recurring costs, came to $6.02 per share. The results topped Wall Street expectations.
For the second quarter, total revenues increased 9% to $9.2 billion in comparison to the second quarter of 2024. Product sales grew 9%, driven by 13% volume g ...
Amgen (NASDAQ:AMGN) is set to release its earnings on Tuesday, August 5, 2025. Historically, Amgen's stock has shown a ...
Amgen (AMGN) to announce Q2 earnings with expected 6% growth in EPS & revenue. Key acquisitions bolster rare disease pipeline ...
Amgen (AMGN) recently declared a $2.38 dividend per share, continuing its practice of rewarding shareholders, which aligns ...
Analysts estimate that Amgen will report an earnings per share (EPS) of $5.26. The announcement from Amgen is eagerly anticipated, with investors seeking news of surpassing estimates and favorable ...